🔗 Share this article

Grammy-winning R&B singer D’Angelo passed away on the fourteenth of October at 51 years old after a private battle with pancreatic cancer.

“The shining star of our family has faded away for us in this life,” his relatives stated. “After a prolonged and courageous struggle with the disease, we are heartbroken to declare that D’Angelo, recognized by his fans around the world as D’Angelo, has been taken from us.”

D’Angelo left an indelible mark on music with his innovative neo-soul sound and partnerships with high-profile artists.

He released his debut album, “Brown Sugar,” in the mid-nineties to immediate acclaim. The album reached No. 4 on Billboard’s Top R&B Albums chart, went platinum later that year, and received several Grammy nominations.

However, it was his sophomore release, “Voodoo,” in the year 2000 that propelled his artistic journey into the stratosphere. The album premiered at No. 1 on both the R&B charts and the Billboard 200. He received two Grammy Awards: Best R&B Album and Best Male R&B Vocal Performance for “Untitled (How Does It Feel).”

The visual for “Untitled (How Does It Feel)” solidified D’Angelo’s reputation as a icon, albeit a reluctant one, in the cultural zeitgeist. The intimate portrayal showed the singer, famously stripped down to his waist, performing straight into the lens.

D’Angelo retreated from the public eye after releasing Voodoo and openly battled with drugs and alcohol. In 2005, he was part of a severe vehicle accident that left him in critical condition.

Over ten years later, his third and final album, “Black Messiah” (2014), confirmed his lasting popularity with another No. 1 debut on the R&B chart and a award for Top R&B Record.

Again, in his own mysterious way, D’Angelo made only a few public appearances in the subsequent period.

The singer was scheduled as a headliner for the 2025 Roots Picnic festival, but his appearance was canceled, due to an “unforeseen medical delay.”

Even though information is limited about D’Angelo’s health in the weeks before his death, he had reportedly been in the hospital for months and in palliative care for a fortnight.

D’Angelo’s demise is a clear example of the harmful impact of pancreatic malignancy, one of the deadliest and least preventable types of the disease, on a gifted artist whose existence was ended too soon.

“We are saddened that he can only provide cherished moments with his family, but we are eternally grateful for the heritage of extraordinarily moving music he has left us,” his family expressed.

Pancreatic Malignancy: Deadly and Rarely Preventable

Pancreatic cancer affects the pancreas, a tiny gland that generates the hormone insulin and is vital in digestion, among other functions. The size and location of the pancreas in the body make it more difficult to identify cancer.

Although this cancer accounts for only approximately three percent of malignancy cases each year in the U.S., it is responsible for seven percent of cancer deaths.

Nearly seventy thousand individuals will be found to have pancreatic cancer and about 52,000 will succumb to the illness in 2025.

“Pancreatic cancer is one of the most lethal diseases, with an fast-growing mass and dismal outcomes. We have limited and poor treatment options, and a smaller window to make a meaningful impact on the lives of people,” noted a medical oncologist.

Because this disease seldom produces initial signs, it’s frequently diagnosed only after the disease is late-stage. Even when a patient has indicators they are usually vague and may be mistaken for a several everyday ailments.

“As of yet, there is no good way to detect this malignancy in the initial phases, except for paying attention to physical changes and speaking with your doctor if there are new or unusual signs,” said a medical director.

Common symptoms of this disease encompass:

• discomfort in the stomach or back
• weight loss
• jaundice
• loss of appetite
• brownish urine
• pale or fatty bowel movements
• diarrhea
• increased appetite or thirst
• feeling sick

At 51 years old, D’Angelo’s death is an outlier, as pancreatic cancer is typically found in individuals in the 65 to 75 range. However, numerous malignancies, including this type, have become more common in younger people.

“Pancreatic cancer identified before the age of 50 is deemed uncommon, yet alarmingly, clinicians are noticing a rising count of younger patients suffering from this disease,” commented a specialist.

Family History Impacts Disease Probability

Without reliable screening tools for pancreatic cancer, professionals stressed the significance of knowing your family’s health background. Some risk factors, such as tobacco use and obesity also have an influence in the onset of this disease.

Black individuals have the greatest occurrence of pancreatic cancer in the U.S. and are most likely to be found to have inoperable cancer.

“The first step toward lowering one’s chance of this condition is understanding individual susceptibility. Individuals should examine their family history, genetic background, and health issues, such as diabetes, chronic pancreatitis, or obesity that may raise their susceptibility,” said a specialist.

Inherited genetic risk factors are linked to as much as 10% of all pancreatic cancer instances. If someone in your household has had pancreatic cancer, you may want to consider DNA analysis.

“For individuals with a family history of pancreatic cancer or those having high risk genetic mutations, checking may involve advanced imaging such as MRI scans or endoscopic ultrasound (EUS) to find initial alterations in the pancreas,” he explained.

For those looking to lower their chance, lifestyle changes may have an effect. The best step you can take to reduce your susceptibility of this disease is to quit smoking, and if you are a non-smoker, stay away altogether.

Excessive drinking is linked to pancreas inflammation, a risk factor for this malignancy, so limiting or abstaining from alcohol may help lower your chance.

Managing your weight or losing weight may also help reduce your risk. People with obesity are twenty percent more prone to develop this disease. This malignancy also occurs more often in people with blood sugar issues, and reducing weight can also lower the chance of type 2 diabetes.

Despite this disease’s grim outlook, there is still hope.

“We are doing better with therapies and more recent combination chemotherapy. There are developing targeted therapies that are already making an impact,” said a expert.

For numerous individuals, however, education about this uncommon but {dev